News Parkinson's charity partners Biognosys on biomarker project A new R&D project will try to develop assays for LRRK2, a biomarker linked to Parkinson's that has emerged as a major drug target in the disease.
News Servier and Oncodesign announce Parkinson's R&D tie-up Servier and Oncodesign have announced a strategic partnership for R&D into potential drug candidates for Parkinson’s disease.
News UK says it has hit target on commercial trial set-up times The UK has made progress in its efforts to slash set-up times for clinical trials, one of the factors blamed for a decline in industry-backed studies.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.